Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/29754| Title: | The effect of Anakinra on Quality-of-Life in a family with colchicine-resistant FMF | Authors: | VAN DER HILST, Jeroen Lijnen, A. |
Issue Date: | 2015 | Source: | Pediatric Rheumatology, 13(1), p. 108-108 | Abstract: | About 5-10% of patients with FMF do not to colchicine treatment to control inflammation. In these patients anti-IL1 therapy seems to be effective in controlling inflammation, although clinical trials are lacking. However, many patients on Anakinra experience side effects including headache and injection-site reactions. How Anakinra treatment influences quality-of-life (QoL) in these patients is unknown. | Document URI: | http://hdl.handle.net/1942/29754 | DOI: | 10.1186/1546-0096-13-S1-P108 | Rights: | 2015 van der Hilst and Lijnen This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/ publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. | Category: | M | Type: | Journal Contribution |
| Appears in Collections: | Research publications |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| published abstract.pdf | Published version | 262.73 kB | Adobe PDF | View/Open |
Page view(s)
106
checked on Sep 7, 2022
Download(s)
148
checked on Sep 7, 2022
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.